Dendreon Corp.: The Biggest Loser in Biotech Today

After popping 15% yesterday after the company released earnings, shares of Dendreon Corp. (NASDAQOTH: DNDNQ  ) slipped back 7% today, showing that investors may have sobered up after taking time to digest the earnings news. The company did sell more of its drug Provenge than expected, showing a sequential improvement of 10% to $74.8 million in sales, but in this video, Motley Fool health-care analyst David Williamson reminds investors that this is still down from the $85.5 million for the company last year. He also notes that management has said Q1 of 2014 would more closely resemble Q1 of 2013, which posted the disastrous sales figure of $67.6 million. David stresses how vital sales growth is for Dendreon today, and emphasizes how essential it is for the company to avoid these backslides.

Biotech volatility hurts. Here are three stalwart long-term buys to make you feel better.
As every savvy investor knows, Warren Buffett didn't make billions by betting on half-baked stocks. He isolated his best few ideas, bet big, and rode them to riches, hardly ever selling. You deserve the same. That's why our CEO, legendary investor Tom Gardner, has permitted us to reveal The Motley Fool's 3 Stocks to Own Forever. These picks are free today! Just click here now to uncover the three companies we love. 


Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 05, 2014, at 7:01 AM, djtherex wrote:

    It is well time for you fkers to back off from slamming Dendreon!!! You act like the value of their ACI platform is fking worthless and that they are not making significant progress toward profitability, which they are. Bringing an entirely new technique to market is far from easy but in the end they will be successful. People like you should be ashamed of yourselves for your blatantly biased misrepresentation of the true value locked up in the company and its science.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2863911, ~/Articles/ArticleHandler.aspx, 12/19/2014 3:05:46 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement